DGNMF (Diagnamed Holdings) Pretax Margin %: % (As of Mar. 2026)


What is Diagnamed Holdings Pretax Margin %?

Diagnamed Holdings DGNMF +9.03% Pretax Margin % is % as of Mar. 2026. The stock has 1 warning sign investors should review. Among 665 Healthcare Providers & Services companies, Diagnamed Holdings ranks worse than 150375.79% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Diagnamed Holdings's Pre-Tax Income for the three months ended in Mar. 2026 was $-0.09 Mil. Diagnamed Holdings's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Diagnamed Holdings's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for Diagnamed Holdings's Pretax Margin % or its related term are showing as below:


DGNMF's Pretax Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4
* Ranked among companies with meaningful Pretax Margin % only.

Diagnamed Holdings  (OTCPK:DGNMF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Diagnamed Holdings Pretax Margin % Related Terms


Diagnamed Holdings Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Diagnamed Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnamed Holdings Pretax Margin % Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Pretax Margin %
0.00 0.00 0.00 0.00 0.00

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DGNMF vs VEEV, BTSG, TEM: Pretax Margin % Comparison

For the Health Information Services subindustry, Diagnamed Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnamed Holdings Pretax Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's Pretax Margin % falls into.



Diagnamed Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Diagnamed Holdings's Pretax Margin for the fiscal year that ended in Sep. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-1.014/0
= %

Diagnamed Holdings's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.093/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Diagnamed Holdings (DGNMF) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Diagnamed Holdings and its competitors. According to the industry distribution chart, Diagnamed Holdings ranks #999999 out of 665 companies in the Healthcare Providers & Services industry.
Is Diagnamed Holdings' Pretax Margin % too high?
Diagnamed Holdings' current Pretax Margin % is %. Based on the distribution chart, Diagnamed Holdings ranks #999999 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Diagnamed Holdings' Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Diagnamed Holdings ranks #999999 out of 665 companies for Pretax Margin %. This places Diagnamed Holdings in the lower half of its industry. The industry median Pretax Margin % is 4.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.00, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Diagnamed Holdings and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnamed Holdings's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (DGNMF) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Diagnamed Holdings (DGNMF), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnamed Holdings Business Description

Other Exchanges DMED:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.